TSW
MED icon

Thompson Siegel & Walmsley’s Medifast MED Stock Holding History

Thompson Siegel & Walmsley’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-668,343
Closed -$17.5M – 673
2013
Q4 		$17.5M Sell
668,343
-85,066
-11% -$2.18M 0.41% 91
2013
Q3 		$20.3M Sell
753,409
-23,256
-3% -$622K 0.44% 83
2013
Q2 		$20M Buy
+776,665
New +$20.4M 0.43% 84

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
GGPE
Golden Gate Private Equity San Francisco, California $241M AUM 13.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Thompson Siegel & Walmsley's MED Position: Q1 2014 in Review

Thompson Siegel & Walmsley sold out of Medifast (MED) in Q1 2014, closing a stake of 668,343 shares — an estimated $17.5M sold.

Thompson Siegel & Walmsley first reported a position in MED in Q2 2013 and held it in 3 quarters. The position peaked at $20.3M in Q3 2013. 132 funds tracked by Wall St. Rank hold MED as of Q1 2014.

  • Thompson Siegel & Walmsley reported no remaining Medifast position as of Q1 2014 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 668,343 Medifast shares in Q1 2014, an estimated $17.5M.
  • Thompson Siegel & Walmsley first reported a position in Medifast in Q2 2013 and held it in 3 quarters.
  • Thompson Siegel & Walmsley's Medifast position peaked at $20.3M in Q3 2013.
  • 132 funds tracked by Wall St. Rank held Medifast as of Q1 2014.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2014, filed 8 May 2014.